chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, COVID-19, Cough, Dizziness
Clinical narrative: Narrative:  Patient completed Pfizer COVID-19 vaccination series in February 2021. Presented after fever, cough, nightsweats, and light-headedness with falls and hospitalized 9/17/21 and initially treated with supportive cares and Lovenox. Developed acute hypoxic respiratory failure and started remdesivir and dexamethasone (9/20-9/23). Discharged to rehab center 10/5/21. Stay prolonged due to COVID isolation protocols and rehab placement.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Night sweats, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient completed Pfizer COVID-19 vaccination series in February 2021. Presented after fever, cough, nightsweats, and light-headedness with falls and hospitalized 9/17/21 and initially treated with supportive cares and Lovenox. Developed acute hypoxic respiratory failure and started remdesivir and dexamethasone (9/20-9/23). Discharged to rehab center 10/5/21. Stay prolonged due to COVID isolation protocols and rehab placement.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Narrative: Pt was hospitalized for respiratory failure due to testing positive for COVID 8-13-21. Patient was vaccinated in a timely manner in Early and late February. Pt recovered from COVID infection and was discharged 8-16-21.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Death, Endotracheal intubation
Clinical narrative: Narrative:  Patient completed COVID19 vaccination series in January 2021. Tested positive for COVID 19 8/13/21 but stayed in independent senior living until 8/23/2 when patient found on the floor and hospitalized for acute hypoxic respiratory failure. Treated with antibiotics for secondary bacterial pneumonia as well as dexamethasone and remdesivir and placed on ventilation, later intubated. History significant for COPD. Patient died 9/24/21 of sepsis from ventilator-associated pneumonia secondary to hypoxic respiratory failure from COVID-19 pneumonia.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Infection, Mechanical ventilation, Pneumonia, Pneumonia bacterial, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient completed COVID19 vaccination series in January 2021. Tested positive for COVID 19 8/13/21 but stayed in independent senior living until 8/23/2 when patient found on the floor and hospitalized for acute hypoxic respiratory failure. Treated with antibiotics for secondary bacterial pneumonia as well as dexamethasone and remdesivir and placed on ventilation, later intubated. History significant for COPD. Patient died 9/24/21 of sepsis from ventilator-associated pneumonia secondary to hypoxic respiratory failure from COVID-19 pneumonia.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis
Clinical narrative: Narrative:  Patient completed COVID19 vaccination series in January 2021. Tested positive for COVID 19 8/13/21 but stayed in independent senior living until 8/23/2 when patient found on the floor and hospitalized for acute hypoxic respiratory failure. Treated with antibiotics for secondary bacterial pneumonia as well as dexamethasone and remdesivir and placed on ventilation, later intubated. History significant for COPD. Patient died 9/24/21 of sepsis from ventilator-associated pneumonia secondary to hypoxic respiratory failure from COVID-19 pneumonia.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 antibody test, SARS-CoV-2 test positive
Clinical narrative: Narrative:
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2
Clinical narrative: Narrative: Wife got COVID and had to be hospitalized. Patient was placed urgently in HCF due wife being admitted. He declined regeneron. Patient remains in HCF
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Pt was COVID positive 7/16; was admitted to hospital; died 8/3
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient was vaccinated against COVID-19 on 1/14/2021 and 2/4/21 and developed COVID-19 infection 9/25/21.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, Dyspnoea, Hypoaesthesia
Clinical narrative: Narrative: A 48yo obese male with PMH of multiple medical problems which  include Hyperlipidemia, DM, Traumatic Brain Injury, Mild cognitive Disorder,  Traumatic Arthritis, Arthralgia of ankle and foot, Chronic Back Pain, Chronic  PTSD, Asthma and Sleep Apnea. He received his first Pfizer Covid - 19 vaccine  per protocol at the hospital, on October 6, 2021, Per Primary Care Secure messaging  to the ADR reporting Unit's Clinical Pharmacist, on October 14, 2021 ; The  patient reported Pfizer Covid -19 vaccine induced ADR of Facial Numbness,  Trouble Breathing and Spiking blood glucose level.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  pt passed away, unknown cause at this time
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: Narrative:  Pt was vaccinated at a pharmacy with Moderna MRNA vaccine either 4/9 or 4/12 per notes. Pt reported to have "mini stroke" 2 days later. Pt was seen at a site for this. He did follow up for neurology consult post stroke, but all stroke related medical attention was at another site. Patient stated it was recommended by other provider that he not get 2nd dose of vaccine.
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Diarrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: Patient was immunized in timely manner with Pfizer mRNA vaccine.  The course for COVID was generally unremarkable with patient presenting with no  symptoms with the exception of mild diarrhea. Hospital stay was unrelated to  COVID.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Pruritus, Urticaria
Clinical narrative: 44 year-old male with a PMH of anxiety, and migraine presented to the ED 1 hour after receiving first dose of COVID 19 vaccine in the medical clinic. 5-10 minutes after receiving the vaccine, patient began to report pruritic in left wrist that increased to his head, back, flanks, and stomach. Patient then began noticing pain in right leg. He was given cetirizine 10 mg and orange juice without any reliefs. Then, the patient developed gives and redness appearing on left forearm. He was then sent to ED for further evaluation since his symptoms were not improving. In ED, patient states itching has improved, hives have resolved, and has mild pain to lateral right leg. Denies chest pain, palpitations, shortness of breath, chest tightness, headache, abdominal pain, N/V, prior vaccine reaction. Vital signs were stable in the ED and no signs of distress or anaphylaxis. The ED provider recommended if the patient would like to get the second dose, he should take benadryl beforehand. Additionally, the patient was discharged home with diphenhydramine as needed for itchiness.
Age: 100.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  99 yo patient receiving hospice care expired on 8/9/21 after receiving COVID-19 vaccine on 1/26/21
Age: 68.0
Sex: F
Vaccine: FLUX
Symptoms: Dyspnoea, Vomiting
Clinical narrative: Narrative:  A 67yo female with PMH that included Hypertension, hyperlipidemia, Cervicalgia, Low Back Pain, Osteoarthritis, Migraine, Depression and Insomnia. On September 23, 2021 the patient's Primary Care physician reported a historical ADR of influenza vaccine induced abdominal pain. The ADR report included a note that read " after PT and then flus shot, had dyspnea and vomiting. Unclear but she was seen in urgent medical setting and was told it might be allergic reaction" No Flu Immunization record. The report did not include which flu vaccine, when and where it was administered.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Gastrointestinal carcinoma, Gastrointestinal haemorrhage, SARS-CoV-2 test positive
Clinical narrative: Hospitalization occurred but this was due to GI bleed which could be attributed to her GI cancer.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Aspartate aminotransferase increased, Blood creatine phosphokinase increased, Blood phosphorus decreased, Blood potassium decreased, Blood sodium decreased
Clinical narrative: Narrative:
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fall, Haemoglobin decreased, Lymphopenia, Platelet count decreased
Clinical narrative: Narrative:
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, SARS-CoV-2 test positive, White blood cell count increased
Clinical narrative: Narrative:
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: time course) and treatment, if any:    Narrative:
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Burning sensation, Pruritus, Rash, Varicella
Clinical narrative: Narrative:  64-year old male patient with a PMH of HTN reported to his primary care doctor he had small chicken pox eruption on his stomach, itching and burning for 2 weeks after he received first dose of Shingrix vaccine. Denied any difficulty in breathing. He used calamine lotion to relieve symptoms. He was schedule for a second dose in December and wanted to ask his primary care doctor if he should get it. The primary care provider stated it was difficult to diagnose the rash since she did not have the change to see the rash. Additionally, Shingrix does not cause shingle-like rash. Rash may have been urticaria but she recommended the patient not get the second shot due to symptoms and the patient already got love zoster in 2017.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Narrative:  Patient was immunized at facility. There were no specifications in notes regarding type of rxn patient had to vaccine or which dose. There was a report on 10-20 stating patient had covid 6 week prior. No labs or notes in system regarding infxn
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative:
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Narrative:  Vaccine was given in Feb(second dose of Pfizer) and patient tested positive for COVID in Aug 2021. Unlikely a reaction to the vaccine. Did have breakthrough COVID despite 2 doses of vaccine. Was due for booster at time of infection. Has since recd booster vaccine (10/21)
Age: 74.0
Sex: M
Vaccine: FLUX
Symptoms: Anaphylactic reaction
Clinical narrative: Narrative:  A 73yo male with PMH of Hearing Loss, Solitary Nodule of Lung, Cerebrovascular Accident, Hypertension, Hyperlipidemia, PTSD, Neurocognitive Disorder and Depressive disorder. On September 21, 2021 the patient was reported with a historical  ADR of influenza vaccine induced anaphylaxis by ED Physician Assistant. It was updated from initial NKA in the ED, upon patient's admission to unit. The ADR report did not include which influenza vaccine, manufacturer's name, Lot #, who administered it, where and when it was administered, Unable to fine Flu immunization record.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Death, Exposure to SARS-CoV-2, Haemoglobin decreased
Clinical narrative: Narrative:  Patient received 2 doses of Moderna COVID 19 vaccine. Patient reported vomiting and weakness in July 2021, then reported COVID-19 exposure, then was diagnosed with COVID and hospitalized at community hospital. Records for that hospitalization not available to this author. Patient was then in rehab facility and returned home 10/19/21. He was in a weakened state and hypotensive and medications were adjusted. On 10/16/21 he was again taken to local hospital due to weakness and syncope. His hgb was 7 mg/dL and he received a transfusion. Hospital records not currently available to this author. Patient was discharged home with hospice services and expired on 11/19/21.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Syncope, Transfusion, Vomiting
Clinical narrative: Narrative:  Patient received 2 doses of Moderna COVID 19 vaccine. Patient reported vomiting and weakness in July 2021, then reported COVID-19 exposure, then was diagnosed with COVID and hospitalized at community hospital. Records for that hospitalization not available to this author. Patient was then in rehab facility and returned home 10/19/21. He was in a weakened state and hypotensive and medications were adjusted. On 10/16/21 he was again taken to local hospital due to weakness and syncope. His hgb was 7 mg/dL and he received a transfusion. Hospital records not currently available to this author. Patient was discharged home with hospice services and expired on 11/19/21.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anaemia, Arthralgia, Back pain, Benign prostatic hyperplasia
Clinical narrative: Narrative: 75yo male pt with the following problem list: E87.6 Hypokalemia (SCT 43339004) I13.10 Renal failure (SCT 42399005) E83.42 Primary hypomagnesemia (SCT 80710001) J43.8 Pulmonary emphysema (SCT 87433001) M54.5 Backache (SCT 161891005) I50.40 Congestive hear failure (SCT 42343007) N52.9 History of male erectile disorder (SCT 429031006) H90.0 Hearing loss (SCT 15188001) 356.9 Unspecified idiopathic peripheral neuropathy (ICD-9-CM 356.9) 443.9 Intermittent Claudication (ICD-9CM 443.9) E11.9 Diabetes mellitus (SCT 73211009) R80.0 Proteinuria (SCT 29738008) D64.9 Anemia (SCT 21737000) 719.41 Pain in joint involving shoulder region (ICD-9-CM 719.41) 782.1 Rash (ICD-9-CM 782.1) V67.9 Unspecified Follow-Up Examination (ICD-9-CM V65.9) I10. Hypertension (SCT 38341003) E78.2 Hyperlipidemia (SCT 5582204) I10. Hypertension (SCT 110483000) 794.31 Nonspecific abnormal electrocardiogram (ECG) (EKG) (ICD-9-CM 794.31) 600.00 Hypertrophy (Benign) of Prostate without Urinary obstruction (ICD-9-CM 600.00) K21.9 Gastroesophageal reflux disease (SCT 235595009) Patient self-presented to Emergency Facility Emergency Notification Intake Date Presenting to the Facility: 1/5/2022 Care Hospital: Chief complaint: Shortness of Breath Primary Diagnosis: Patient Admitted? Yes of Admission: ER Date/Time of Admission: 1/5/2022 Admitting Diagnosis: Acute hypoxic respiratory failure per health prtal-remains inpatient- Transferred to ICU 1/8/2022 for worsening respiratory and mental status; Continue aggressive oxygen supplementation, Continue antibiotics, Await pathology from bronc Continue Precedex. Pt expired 1/13/2022 @1344 of note pt had another ER visit on  12/10/2021 to same facility as above for Chief complaint: Unspecified complication of genitourinary prosthetic device AND previous to this, another ER visit on 12/8/21 to same facility for urinary retention. Pt had received covid vaccines on 4/1/21 & 4/22/21. Likely this death is not related to covid vaccines.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Complication associated with device, Deafness, Death, Diabetes mellitus
Clinical narrative: Narrative: 75yo male pt with the following problem list: E87.6 Hypokalemia (SCT 43339004) I13.10 Renal failure (SCT 42399005) E83.42 Primary hypomagnesemia (SCT 80710001) J43.8 Pulmonary emphysema (SCT 87433001) M54.5 Backache (SCT 161891005) I50.40 Congestive hear failure (SCT 42343007) N52.9 History of male erectile disorder (SCT 429031006) H90.0 Hearing loss (SCT 15188001) 356.9 Unspecified idiopathic peripheral neuropathy (ICD-9-CM 356.9) 443.9 Intermittent Claudication (ICD-9CM 443.9) E11.9 Diabetes mellitus (SCT 73211009) R80.0 Proteinuria (SCT 29738008) D64.9 Anemia (SCT 21737000) 719.41 Pain in joint involving shoulder region (ICD-9-CM 719.41) 782.1 Rash (ICD-9-CM 782.1) V67.9 Unspecified Follow-Up Examination (ICD-9-CM V65.9) I10. Hypertension (SCT 38341003) E78.2 Hyperlipidemia (SCT 5582204) I10. Hypertension (SCT 110483000) 794.31 Nonspecific abnormal electrocardiogram (ECG) (EKG) (ICD-9-CM 794.31) 600.00 Hypertrophy (Benign) of Prostate without Urinary obstruction (ICD-9-CM 600.00) K21.9 Gastroesophageal reflux disease (SCT 235595009) Patient self-presented to Emergency Facility Emergency Notification Intake Date Presenting to the Facility: 1/5/2022 Care Hospital: Chief complaint: Shortness of Breath Primary Diagnosis: Patient Admitted? Yes of Admission: ER Date/Time of Admission: 1/5/2022 Admitting Diagnosis: Acute hypoxic respiratory failure per health prtal-remains inpatient- Transferred to ICU 1/8/2022 for worsening respiratory and mental status; Continue aggressive oxygen supplementation, Continue antibiotics, Await pathology from bronc Continue Precedex. Pt expired 1/13/2022 @1344 of note pt had another ER visit on  12/10/2021 to same facility as above for Chief complaint: Unspecified complication of genitourinary prosthetic device AND previous to this, another ER visit on 12/8/21 to same facility for urinary retention. Pt had received covid vaccines on 4/1/21 & 4/22/21. Likely this death is not related to covid vaccines.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram abnormal, Emphysema, Gastrooesophageal reflux disease, Hyperlipidaemia
Clinical narrative: Narrative: 75yo male pt with the following problem list: E87.6 Hypokalemia (SCT 43339004) I13.10 Renal failure (SCT 42399005) E83.42 Primary hypomagnesemia (SCT 80710001) J43.8 Pulmonary emphysema (SCT 87433001) M54.5 Backache (SCT 161891005) I50.40 Congestive hear failure (SCT 42343007) N52.9 History of male erectile disorder (SCT 429031006) H90.0 Hearing loss (SCT 15188001) 356.9 Unspecified idiopathic peripheral neuropathy (ICD-9-CM 356.9) 443.9 Intermittent Claudication (ICD-9CM 443.9) E11.9 Diabetes mellitus (SCT 73211009) R80.0 Proteinuria (SCT 29738008) D64.9 Anemia (SCT 21737000) 719.41 Pain in joint involving shoulder region (ICD-9-CM 719.41) 782.1 Rash (ICD-9-CM 782.1) V67.9 Unspecified Follow-Up Examination (ICD-9-CM V65.9) I10. Hypertension (SCT 38341003) E78.2 Hyperlipidemia (SCT 5582204) I10. Hypertension (SCT 110483000) 794.31 Nonspecific abnormal electrocardiogram (ECG) (EKG) (ICD-9-CM 794.31) 600.00 Hypertrophy (Benign) of Prostate without Urinary obstruction (ICD-9-CM 600.00) K21.9 Gastroesophageal reflux disease (SCT 235595009) Patient self-presented to Emergency Facility Emergency Notification Intake Date Presenting to the Facility: 1/5/2022 Care Hospital: Chief complaint: Shortness of Breath Primary Diagnosis: Patient Admitted? Yes of Admission: ER Date/Time of Admission: 1/5/2022 Admitting Diagnosis: Acute hypoxic respiratory failure per health prtal-remains inpatient- Transferred to ICU 1/8/2022 for worsening respiratory and mental status; Continue aggressive oxygen supplementation, Continue antibiotics, Await pathology from bronc Continue Precedex. Pt expired 1/13/2022 @1344 of note pt had another ER visit on  12/10/2021 to same facility as above for Chief complaint: Unspecified complication of genitourinary prosthetic device AND previous to this, another ER visit on 12/8/21 to same facility for urinary retention. Pt had received covid vaccines on 4/1/21 & 4/22/21. Likely this death is not related to covid vaccines.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Hypokalaemia, Hypomagnesaemia, Intensive care, Intermittent claudication
Clinical narrative: Narrative: 75yo male pt with the following problem list: E87.6 Hypokalemia (SCT 43339004) I13.10 Renal failure (SCT 42399005) E83.42 Primary hypomagnesemia (SCT 80710001) J43.8 Pulmonary emphysema (SCT 87433001) M54.5 Backache (SCT 161891005) I50.40 Congestive hear failure (SCT 42343007) N52.9 History of male erectile disorder (SCT 429031006) H90.0 Hearing loss (SCT 15188001) 356.9 Unspecified idiopathic peripheral neuropathy (ICD-9-CM 356.9) 443.9 Intermittent Claudication (ICD-9CM 443.9) E11.9 Diabetes mellitus (SCT 73211009) R80.0 Proteinuria (SCT 29738008) D64.9 Anemia (SCT 21737000) 719.41 Pain in joint involving shoulder region (ICD-9-CM 719.41) 782.1 Rash (ICD-9-CM 782.1) V67.9 Unspecified Follow-Up Examination (ICD-9-CM V65.9) I10. Hypertension (SCT 38341003) E78.2 Hyperlipidemia (SCT 5582204) I10. Hypertension (SCT 110483000) 794.31 Nonspecific abnormal electrocardiogram (ECG) (EKG) (ICD-9-CM 794.31) 600.00 Hypertrophy (Benign) of Prostate without Urinary obstruction (ICD-9-CM 600.00) K21.9 Gastroesophageal reflux disease (SCT 235595009) Patient self-presented to Emergency Facility Emergency Notification Intake Date Presenting to the Facility: 1/5/2022 Care Hospital: Chief complaint: Shortness of Breath Primary Diagnosis: Patient Admitted? Yes of Admission: ER Date/Time of Admission: 1/5/2022 Admitting Diagnosis: Acute hypoxic respiratory failure per health prtal-remains inpatient- Transferred to ICU 1/8/2022 for worsening respiratory and mental status; Continue aggressive oxygen supplementation, Continue antibiotics, Await pathology from bronc Continue Precedex. Pt expired 1/13/2022 @1344 of note pt had another ER visit on  12/10/2021 to same facility as above for Chief complaint: Unspecified complication of genitourinary prosthetic device AND previous to this, another ER visit on 12/8/21 to same facility for urinary retention. Pt had received covid vaccines on 4/1/21 & 4/22/21. Likely this death is not related to covid vaccines.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Mental status changes, Neuropathy peripheral, Proteinuria, Rash, Renal failure
Clinical narrative: Narrative: 75yo male pt with the following problem list: E87.6 Hypokalemia (SCT 43339004) I13.10 Renal failure (SCT 42399005) E83.42 Primary hypomagnesemia (SCT 80710001) J43.8 Pulmonary emphysema (SCT 87433001) M54.5 Backache (SCT 161891005) I50.40 Congestive hear failure (SCT 42343007) N52.9 History of male erectile disorder (SCT 429031006) H90.0 Hearing loss (SCT 15188001) 356.9 Unspecified idiopathic peripheral neuropathy (ICD-9-CM 356.9) 443.9 Intermittent Claudication (ICD-9CM 443.9) E11.9 Diabetes mellitus (SCT 73211009) R80.0 Proteinuria (SCT 29738008) D64.9 Anemia (SCT 21737000) 719.41 Pain in joint involving shoulder region (ICD-9-CM 719.41) 782.1 Rash (ICD-9-CM 782.1) V67.9 Unspecified Follow-Up Examination (ICD-9-CM V65.9) I10. Hypertension (SCT 38341003) E78.2 Hyperlipidemia (SCT 5582204) I10. Hypertension (SCT 110483000) 794.31 Nonspecific abnormal electrocardiogram (ECG) (EKG) (ICD-9-CM 794.31) 600.00 Hypertrophy (Benign) of Prostate without Urinary obstruction (ICD-9-CM 600.00) K21.9 Gastroesophageal reflux disease (SCT 235595009) Patient self-presented to Emergency Facility Emergency Notification Intake Date Presenting to the Facility: 1/5/2022 Care Hospital: Chief complaint: Shortness of Breath Primary Diagnosis: Patient Admitted? Yes of Admission: ER Date/Time of Admission: 1/5/2022 Admitting Diagnosis: Acute hypoxic respiratory failure per health prtal-remains inpatient- Transferred to ICU 1/8/2022 for worsening respiratory and mental status; Continue aggressive oxygen supplementation, Continue antibiotics, Await pathology from bronc Continue Precedex. Pt expired 1/13/2022 @1344 of note pt had another ER visit on  12/10/2021 to same facility as above for Chief complaint: Unspecified complication of genitourinary prosthetic device AND previous to this, another ER visit on 12/8/21 to same facility for urinary retention. Pt had received covid vaccines on 4/1/21 & 4/22/21. Likely this death is not related to covid vaccines.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Urinary retention
Clinical narrative: Narrative: 75yo male pt with the following problem list: E87.6 Hypokalemia (SCT 43339004) I13.10 Renal failure (SCT 42399005) E83.42 Primary hypomagnesemia (SCT 80710001) J43.8 Pulmonary emphysema (SCT 87433001) M54.5 Backache (SCT 161891005) I50.40 Congestive hear failure (SCT 42343007) N52.9 History of male erectile disorder (SCT 429031006) H90.0 Hearing loss (SCT 15188001) 356.9 Unspecified idiopathic peripheral neuropathy (ICD-9-CM 356.9) 443.9 Intermittent Claudication (ICD-9CM 443.9) E11.9 Diabetes mellitus (SCT 73211009) R80.0 Proteinuria (SCT 29738008) D64.9 Anemia (SCT 21737000) 719.41 Pain in joint involving shoulder region (ICD-9-CM 719.41) 782.1 Rash (ICD-9-CM 782.1) V67.9 Unspecified Follow-Up Examination (ICD-9-CM V65.9) I10. Hypertension (SCT 38341003) E78.2 Hyperlipidemia (SCT 5582204) I10. Hypertension (SCT 110483000) 794.31 Nonspecific abnormal electrocardiogram (ECG) (EKG) (ICD-9-CM 794.31) 600.00 Hypertrophy (Benign) of Prostate without Urinary obstruction (ICD-9-CM 600.00) K21.9 Gastroesophageal reflux disease (SCT 235595009) Patient self-presented to Emergency Facility Emergency Notification Intake Date Presenting to the Facility: 1/5/2022 Care Hospital: Chief complaint: Shortness of Breath Primary Diagnosis: Patient Admitted? Yes of Admission: ER Date/Time of Admission: 1/5/2022 Admitting Diagnosis: Acute hypoxic respiratory failure per health prtal-remains inpatient- Transferred to ICU 1/8/2022 for worsening respiratory and mental status; Continue aggressive oxygen supplementation, Continue antibiotics, Await pathology from bronc Continue Precedex. Pt expired 1/13/2022 @1344 of note pt had another ER visit on  12/10/2021 to same facility as above for Chief complaint: Unspecified complication of genitourinary prosthetic device AND previous to this, another ER visit on 12/8/21 to same facility for urinary retention. Pt had received covid vaccines on 4/1/21 & 4/22/21. Likely this death is not related to covid vaccines.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Diarrhoea, Infection, Nausea
Clinical narrative: Narrative:  PT WAS VACCINATED IN TIMELY MANNER WITH PFIZER MRNA VACCINE. PATIENT'S INFECTION HAD ESSENTIALLY NO LUNG INVOLVEMENT, BUT HE EXPERIENCE SIGNIFICANT NAUSEA, VOMITING, DIARRHEA RESULTING IN WEAKNESS AND WEIGHT LOSS. AFTER SHORT HOSPITAL STAY, PT IMPROVED AND WAS DISCHARGED
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting, Weight decreased
Clinical narrative: Narrative:  PT WAS VACCINATED IN TIMELY MANNER WITH PFIZER MRNA VACCINE. PATIENT'S INFECTION HAD ESSENTIALLY NO LUNG INVOLVEMENT, BUT HE EXPERIENCE SIGNIFICANT NAUSEA, VOMITING, DIARRHEA RESULTING IN WEAKNESS AND WEIGHT LOSS. AFTER SHORT HOSPITAL STAY, PT IMPROVED AND WAS DISCHARGED
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 89 year old male who was at nursing facility under facility contract passed away on january 13, 2022. Pt had the following problem list: PROBLEM LAST MOD PROVIDER End-stage renal disease 08/03/2018 (ICD-10-CM N18.6) Hyperparathyroidism due to renal insufficiency 08/03/2018 (ICD-10-CM N25.81) Legal blindness (ICD-10-CM H54.8) 08/24/2016 Diastolic heart failure 04/25/2016 (ICD-10-cm I50.32) Chronic kidney disease stage 3 03/10/2016 (ICD-10-CM N18.3) Delirium (ICD-9-CM 293.0) 08/12/2015 Hyperpotassemia (ICD-9-CM 276.7) 05/08/2014 Other B-complex deficiencies (ICD-9-CM 266.2) 05/08/2014 Inguinal hernia, without mention of obstruction 04/08/2004 or gangrene (ICD-9-CM 550.90) Chronic airway obstruction. Not Elsewhere 06/11/2013 Classified (ICD-9-CM 496.) (ICD-10-CM Z95.0); Presence of cardiac pacemaker 02/29/2016 not known (ICD-9-CM 209.41); Benign Carcinoid Tumor of the 07/17/2012 Duodenum (ICD-9-CM 209.41) (ICD-9-CM 588.81); Secondary Hyperparathyroidism 07/12/2012 (of Renal Origin) (ICD-9-cm 588.81) (ICD-9-CM 428.0); (ICD-9-CM 428.0) 02/16/2012 (ICD-9-CM 276.8); Hypokalemia (ICD-9-CM 276.8) 02/16/2012 (ICD-9 416.8); Pulmonary Hypertension 08/23/2010 (ICD-9-CM 416.8) (ICD-9-CM V71.89); Observation for other 04/20/2010 specified suspected Condition (ICD-9-V71.89) Coronary Artery Disease 02/01/2016 (ICD-10-CM Z95.0), Onset 04/00/2010 Non-obstructive, single-vessel (30% LAD) Chronic Kidney Disease, Stage III (Moderate) 04/19/2010 (ICD-9-CM 585.3), Onset 04/00/2010 (ICD-9-CM 427.32); Atrial Flutter (ICD-9-CM 10/20/2009 427.32) (ICD-9-CM 729.81); Swelling of limb (ICD-9-CM 06/16/2009 729.81) (ICD-9-CM 250.00); Diabetes Mellitus Type II or 06/19/2008 unspecified (ICD-9-CM 250.00) (ICD-9-CM 272.4); Hyperlipidemia (ICD-9-CM 06/19/2008 272.4) (ICD-9-CM 727.05); Other tenosynovitis of hand 03/03/2008 and wrist (ICD-9-CM 727.05) (ICD-9-CM 719.00); Joint Effusion (ICD-9-CM 12/31/2007 719.00) (ICD-9-CM 719.47); Pain in joint involving ankle 08/11/2007 and foot (ICD-9-CM 719.47) (ICD-9-CM 782.3); Edema (ICD-9-CM 782.3) 04/29/2007 (ICD-9-CM 426.6); Other heart block (ICD-9-CM 04/20/2007 426.6) (ICD-9-CM 389.10); SENSORNEUR HEAR LOSS 03/07/2005 Cardiac dysrhythmia (ICD-9-CM 427.9) 05/17/2000 Essential Hypertension (ICD-10-CM 04/25/2016 I10.) Pt had received covid vaccines on 4/1/21 & 4/29/21. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & death & date of vaccine administrations.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Cough, Decreased appetite, Diarrhoea, Dyspnoea
Clinical narrative: Narrative:  86 year old male admitted on 1/13/22 for increasing SOB, chills, fatigue, nonproductive cough, decreased appetite and diarrhea. He had been vaccinated x 2 with Moderna vaccines (1st dose 1/19/21, 2nd dose 2/16/21). He was treated with remdesivir x 5 days and prednisone x 7 days.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue
Clinical narrative: Narrative:  86 year old male admitted on 1/13/22 for increasing SOB, chills, fatigue, nonproductive cough, decreased appetite and diarrhea. He had been vaccinated x 2 with Moderna vaccines (1st dose 1/19/21, 2nd dose 2/16/21). He was treated with remdesivir x 5 days and prednisone x 7 days.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cough, Death, Dyspnoea
Clinical narrative: Narrative: PATIENT WAS VACCINATED WITH MODERNA MRNA VACCINE  OUTSIDE OF THE HOSPITAL IN TIMELY MANNER 1/20 AND 2/17  RESPECTIVELY. PATIENT LIVED IN LTCF WITH MULTIPLE HEALTH  COMPLICATIONS INCLUDING ESRD POST RENAL TRANSPLANT. PT  WAS DIAGNOSED WITH COVID AT HIS FACILITY ON 10-15 AND WAS  BROUGHT TO THE HOSPITAL WITH PROGRESIVE SYMPTOMS OF FEVER, NON  PRODUCTIVE COUGH, DYSPNEA HE WAS FOUND TO BE  ENCEPHALOPATHIC BY NURSING STAFF AND 02 SATS WERE IN MID  80S WHICH PROMTED VISIT TO HOSPITAL ED. PT REQUIRED SUPPLEMENTAL  02 OF UP TO 15 LITERS DURING STAY. PT SUFFEREED FROM COVID-  PNEUMONIA AND ENTEROCOCCUS FAECIUM DURING HOSPITAL STAY.  PATIENT SUCCUMBED TO INFECTION AND PASSED AWAY 10-16-21 CAUSE  OF DEAHT COVID-PNEUMONIA
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Encephalopathy, Enterococcal infection, Laboratory test, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative: PATIENT WAS VACCINATED WITH MODERNA MRNA VACCINE  OUTSIDE OF THE HOSPITAL IN TIMELY MANNER 1/20 AND 2/17  RESPECTIVELY. PATIENT LIVED IN LTCF WITH MULTIPLE HEALTH  COMPLICATIONS INCLUDING ESRD POST RENAL TRANSPLANT. PT  WAS DIAGNOSED WITH COVID AT HIS FACILITY ON 10-15 AND WAS  BROUGHT TO THE HOSPITAL WITH PROGRESIVE SYMPTOMS OF FEVER, NON  PRODUCTIVE COUGH, DYSPNEA HE WAS FOUND TO BE  ENCEPHALOPATHIC BY NURSING STAFF AND 02 SATS WERE IN MID  80S WHICH PROMTED VISIT TO HOSPITAL ED. PT REQUIRED SUPPLEMENTAL  02 OF UP TO 15 LITERS DURING STAY. PT SUFFEREED FROM COVID-  PNEUMONIA AND ENTEROCOCCUS FAECIUM DURING HOSPITAL STAY.  PATIENT SUCCUMBED TO INFECTION AND PASSED AWAY 10-16-21 CAUSE  OF DEAHT COVID-PNEUMONIA
Age: 46.0
Sex: M
Vaccine: FLUX
Symptoms: Dizziness, Immunisation reaction
Clinical narrative: Narrative:  At the time of the report, a 44yo male with PMH of Cervical Spinal Stenosis, Cervical Spondylosis, Cervical Disorder, Nummular Dermatitis and ED. On September 23,2021, his attending physician reported a historical ADR of influenza vaccine induced dizziness classified as moderate. The report did not include influenza vaccine information (which vaccine, Lot #, mfg, who administered the vaccine, when and where it was administered ). Unable to find influenza immunization record.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Coxsackie myocarditis, Musculoskeletal chest pain, Viral myocarditis
Clinical narrative: Narrative: Pt received 1 dose of COVID-19 vaccine (Pfizer) on 08/30/2021. About 3 weeks later, admitted for chest wall pain. Unclear duration of CM, possibilities include viral myocarditis (w/ related viral PNA), vs ETOH-mediated vs COVID vaccine myocarditis, or other. Less likely ischemic w/ young age. Per the ID note, "The primary suspicion is that his CHF is due to a viral myocarditis due to Coxsackie. We have considered COVID vaccination as a potential contributing cause of his symptoms. However, typically mRNA vaccine related myocarditis occurs after the second dose and typically occurs within a few days of the vaccination. His presentation is not consistent with the vast majority of presentations. By criteria, it would only fit as possible association. Overall, he remains not fully vaccinated and his risk of COVID complications is high. We recommend that he get the J&J / Janssen vaccination which is not associated with myocarditis and would offer greater protection than one mRNA vaccine."
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Narrative:  Patient diagnosed with COVID ON 8/12/21 after receiving COVID vaccines on 1/28/21 and 2/25/21.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient tested positive for COVID-19 and was hospitalized despite full vaccination. Pt received Pfizer (2 doses) last one on 02/16/2021. No booster dose was received.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient tested positive for COVID-19 on 8/6/21 despite having received COVID-19 vaccines on 1/14/21 and 2/11/21
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Skin warm
Clinical narrative: Narrative:  Patient receive booster dose for COVID-19 vaccine (Moderna) on 12/23/21. On 12/24/21, noticed arm pain with swelling, redness/warmth in same arm where received vaccine. Seen in urgent care 12/29/21, ruled out thrombosis. Not treated with anything in clinic, nor given rx.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient received COVID-19 vaccines on 1/21/21 and 2/18/21. He was diagnosed with COVID-19 infection, requiring hospitalization, 8/29/21 at local hospital. Those records are not available to this writer at this time.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Dyspnoea exertional, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  PATIENT WAS IMMUNIZED IN A TIMELY MANNER 3-6-21 AND 3-26-21 WITH PFIZER MRNA VACCINE. PATIENT TESTED POSITIVE FOR COVID AFTER PRESENTING TO ER WITH WORSENING SOB DOIG MINIMAL EXERTION. PATIENT WAS ADMITTED FOR HYPOXIA (ON BASELINE O2 AT HOME D/T IPF) 02 NEEDS INCREASED IN HOSPITAL UP TO 6 L WITH ACTIVITY. HE WAS TREATED AND RECEOVERED AFTER LENTHY HOSPITAL STAY.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Asthenia, COVID-19, Chills, Decreased appetite
Clinical narrative: Narrative:  Patient is a 84 year old male who presented to the emergency department 12/10/21 after experiencing including intermittent fever, chills, decreased appetite, generalized weakness. Testing revealed patient was positive for COVID19, lab results also showed hypomagnesemia, hyponatremia and AKI. Patient was admitted for observation and treatment. Patient has a past medical history of CKD, HTN, HLD, GERD, osteoporosis, bronchiectasis, prostate CA s/p XRT and COPD. Treatment included dexamethasone (12/11-12/16). Patient was discharged on 12/23 with supportive medications including albuterol, guaifenesin and benzonatate.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypomagnesaemia, Hyponatraemia, Laboratory test abnormal, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient is a 84 year old male who presented to the emergency department 12/10/21 after experiencing including intermittent fever, chills, decreased appetite, generalized weakness. Testing revealed patient was positive for COVID19, lab results also showed hypomagnesemia, hyponatremia and AKI. Patient was admitted for observation and treatment. Patient has a past medical history of CKD, HTN, HLD, GERD, osteoporosis, bronchiectasis, prostate CA s/p XRT and COPD. Treatment included dexamethasone (12/11-12/16). Patient was discharged on 12/23 with supportive medications including albuterol, guaifenesin and benzonatate.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute myocardial infarction, Anaemia, Anticoagulant therapy, Asymptomatic COVID-19
Clinical narrative: Narrative:  93y.o. MALE Patient with a h/o CKD stage 4, CAD, HTN, HLD; presented to ER with report of fall on 1/9/2022. Per 1/11/2022 MD H&P note regarding covid infxn: "*COVID-19 infection, POA - Tested Positive 1/9/22. Isolation ends 1/20/22. - CXR: No acute cardiopulmonary abnormality grossly seen. - Stable on room air. no respiratory complaints - No indication for steroids or remdesivir" On 1/16/2021 MD progress note: "Myocardial injury - Troponin gotten this morning as part of routine COVID-19 labs and found to be 2.67 and now downtrending. Patient is asymtomatic likely NSTEMI type 2 possibly stress induced cardiomyopathy. Continue Coreg, ASA, Statin. ECHO ordered. Cardiology Hyperkalemia in setting of AKI on CKD4 - improved today, similar to admission. Cr improved since admission. Continue to hold Losartan. COVID+ on admission - asymptomatic, never needed oxygen. No indications for therapy at this time." On 1/18/2021 MD note pt with AKI, POA and the following regarding anemia secondary to CKI: "*Anemia - Hgb dropped to 6.1 on 1/17 - transfused 1 U, rechecked 6.5 and received a 2nd unit PRBCs recheck 9.3 - Fe 40, Transferrin 109 - Family interested in full treatment including EGD if indicated - consult GI" On 1/18/2021 pt coded & died at 21:09pm. Death was caused by: myocardial infarction in setting of COVID-19 infection. Pt had received covid vaccine on 7/9/2021 (J&J). Likely pt's death is not related to covid vaccine given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine abnormal, Blood iron decreased, Cardio-respiratory arrest, Chest X-ray normal, Chronic kidney disease
Clinical narrative: Narrative:  93y.o. MALE Patient with a h/o CKD stage 4, CAD, HTN, HLD; presented to ER with report of fall on 1/9/2022. Per 1/11/2022 MD H&P note regarding covid infxn: "*COVID-19 infection, POA - Tested Positive 1/9/22. Isolation ends 1/20/22. - CXR: No acute cardiopulmonary abnormality grossly seen. - Stable on room air. no respiratory complaints - No indication for steroids or remdesivir" On 1/16/2021 MD progress note: "Myocardial injury - Troponin gotten this morning as part of routine COVID-19 labs and found to be 2.67 and now downtrending. Patient is asymtomatic likely NSTEMI type 2 possibly stress induced cardiomyopathy. Continue Coreg, ASA, Statin. ECHO ordered. Cardiology Hyperkalemia in setting of AKI on CKD4 - improved today, similar to admission. Cr improved since admission. Continue to hold Losartan. COVID+ on admission - asymptomatic, never needed oxygen. No indications for therapy at this time." On 1/18/2021 MD note pt with AKI, POA and the following regarding anemia secondary to CKI: "*Anemia - Hgb dropped to 6.1 on 1/17 - transfused 1 U, rechecked 6.5 and received a 2nd unit PRBCs recheck 9.3 - Fe 40, Transferrin 109 - Family interested in full treatment including EGD if indicated - consult GI" On 1/18/2021 pt coded & died at 21:09pm. Death was caused by: myocardial infarction in setting of COVID-19 infection. Pt had received covid vaccine on 7/9/2021 (J&J). Likely pt's death is not related to covid vaccine given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Fall, Haemoglobin decreased, Hyperkalaemia
Clinical narrative: Narrative:  93y.o. MALE Patient with a h/o CKD stage 4, CAD, HTN, HLD; presented to ER with report of fall on 1/9/2022. Per 1/11/2022 MD H&P note regarding covid infxn: "*COVID-19 infection, POA - Tested Positive 1/9/22. Isolation ends 1/20/22. - CXR: No acute cardiopulmonary abnormality grossly seen. - Stable on room air. no respiratory complaints - No indication for steroids or remdesivir" On 1/16/2021 MD progress note: "Myocardial injury - Troponin gotten this morning as part of routine COVID-19 labs and found to be 2.67 and now downtrending. Patient is asymtomatic likely NSTEMI type 2 possibly stress induced cardiomyopathy. Continue Coreg, ASA, Statin. ECHO ordered. Cardiology Hyperkalemia in setting of AKI on CKD4 - improved today, similar to admission. Cr improved since admission. Continue to hold Losartan. COVID+ on admission - asymptomatic, never needed oxygen. No indications for therapy at this time." On 1/18/2021 MD note pt with AKI, POA and the following regarding anemia secondary to CKI: "*Anemia - Hgb dropped to 6.1 on 1/17 - transfused 1 U, rechecked 6.5 and received a 2nd unit PRBCs recheck 9.3 - Fe 40, Transferrin 109 - Family interested in full treatment including EGD if indicated - consult GI" On 1/18/2021 pt coded & died at 21:09pm. Death was caused by: myocardial infarction in setting of COVID-19 infection. Pt had received covid vaccine on 7/9/2021 (J&J). Likely pt's death is not related to covid vaccine given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test, Myocardial injury, Red blood cell transfusion, SARS-CoV-2 test positive, Transferrin decreased
Clinical narrative: Narrative:  93y.o. MALE Patient with a h/o CKD stage 4, CAD, HTN, HLD; presented to ER with report of fall on 1/9/2022. Per 1/11/2022 MD H&P note regarding covid infxn: "*COVID-19 infection, POA - Tested Positive 1/9/22. Isolation ends 1/20/22. - CXR: No acute cardiopulmonary abnormality grossly seen. - Stable on room air. no respiratory complaints - No indication for steroids or remdesivir" On 1/16/2021 MD progress note: "Myocardial injury - Troponin gotten this morning as part of routine COVID-19 labs and found to be 2.67 and now downtrending. Patient is asymtomatic likely NSTEMI type 2 possibly stress induced cardiomyopathy. Continue Coreg, ASA, Statin. ECHO ordered. Cardiology Hyperkalemia in setting of AKI on CKD4 - improved today, similar to admission. Cr improved since admission. Continue to hold Losartan. COVID+ on admission - asymptomatic, never needed oxygen. No indications for therapy at this time." On 1/18/2021 MD note pt with AKI, POA and the following regarding anemia secondary to CKI: "*Anemia - Hgb dropped to 6.1 on 1/17 - transfused 1 U, rechecked 6.5 and received a 2nd unit PRBCs recheck 9.3 - Fe 40, Transferrin 109 - Family interested in full treatment including EGD if indicated - consult GI" On 1/18/2021 pt coded & died at 21:09pm. Death was caused by: myocardial infarction in setting of COVID-19 infection. Pt had received covid vaccine on 7/9/2021 (J&J). Likely pt's death is not related to covid vaccine given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin increased
Clinical narrative: Narrative:  93y.o. MALE Patient with a h/o CKD stage 4, CAD, HTN, HLD; presented to ER with report of fall on 1/9/2022. Per 1/11/2022 MD H&P note regarding covid infxn: "*COVID-19 infection, POA - Tested Positive 1/9/22. Isolation ends 1/20/22. - CXR: No acute cardiopulmonary abnormality grossly seen. - Stable on room air. no respiratory complaints - No indication for steroids or remdesivir" On 1/16/2021 MD progress note: "Myocardial injury - Troponin gotten this morning as part of routine COVID-19 labs and found to be 2.67 and now downtrending. Patient is asymtomatic likely NSTEMI type 2 possibly stress induced cardiomyopathy. Continue Coreg, ASA, Statin. ECHO ordered. Cardiology Hyperkalemia in setting of AKI on CKD4 - improved today, similar to admission. Cr improved since admission. Continue to hold Losartan. COVID+ on admission - asymptomatic, never needed oxygen. No indications for therapy at this time." On 1/18/2021 MD note pt with AKI, POA and the following regarding anemia secondary to CKI: "*Anemia - Hgb dropped to 6.1 on 1/17 - transfused 1 U, rechecked 6.5 and received a 2nd unit PRBCs recheck 9.3 - Fe 40, Transferrin 109 - Family interested in full treatment including EGD if indicated - consult GI" On 1/18/2021 pt coded & died at 21:09pm. Death was caused by: myocardial infarction in setting of COVID-19 infection. Pt had received covid vaccine on 7/9/2021 (J&J). Likely pt's death is not related to covid vaccine given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Blood pressure increased, Dizziness, Fatigue, Heart rate increased
Clinical narrative: off balance; tension headaches; diagnosed with vestibular migranes; heart rate slightly elevated; blood pressure slightly elevated; States not getting enough sleep; vertigo; dizziness; Episodes of fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (off balance), TENSION HEADACHE (tension headaches), VESTIBULAR MIGRAINE (diagnosed with vestibular migranes), HEART RATE INCREASED (heart rate slightly elevated) and BLOOD PRESSURE INCREASED (blood pressure slightly elevated) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BALANCE DISORDER (off balance), TENSION HEADACHE (tension headaches), VESTIBULAR MIGRAINE (diagnosed with vestibular migranes), HEART RATE INCREASED (heart rate slightly elevated), BLOOD PRESSURE INCREASED (blood pressure slightly elevated), INSOMNIA (States not getting enough sleep), VERTIGO (vertigo), DIZZINESS (dizziness) and FATIGUE (Episodes of fatigue). The patient was treated with LORAZEPAM (ATIVAN) ongoing since an unknown date at an unspecified dose and frequency and VENLAFAXINE HYDROCHLORIDE (EFFEXOR) ongoing since an unknown date at a dose of 75 mg then to raise to 150mg after 1 month. At the time of the report, BALANCE DISORDER (off balance), TENSION HEADACHE (tension headaches), VESTIBULAR MIGRAINE (diagnosed with vestibular migranes), HEART RATE INCREASED (heart rate slightly elevated), BLOOD PRESSURE INCREASED (blood pressure slightly elevated), INSOMNIA (States not getting enough sleep), VERTIGO (vertigo), DIZZINESS (dizziness) and FATIGUE (Episodes of fatigue) outcome was unknown.            The patient reported heart rate and blood pressure slightly elevated but not as bad as after the 1st dose. Further he went to physical therapist to rule out vertigo and went to ENT doctor. The Sunlight Triger  the headache event.  the Ativan medication was taken 15 min prior to receiving 2nd dose. The treatment was for 6 months. The patient has no COVID-19 infection previously.   This case was linked to MOD-2022-467546 (Patient Link).